|
1
|
Basanta D and Anderson ARA: Homeostasis
back and forth: An ecoevolutionary perspective of cancer. Cold
Spring Harb Perspect Med. 7:1–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shiao SL, Ganesan AP, Rugo HS and Coussens
LM: Immune microenvironments in solid tumors: New targets for
therapy. Genes Dev. 25:2559–2572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shinko D, Diakos CI, Clarke SJ and Charles
KA: Cancer-related systemic inflammation: The challenges and
therapeutic opportunities for personalized medicine. Clin Pharmacol
Ther. 102:599–610. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Janssen LME, Ramsay EE, Logsdon CD and
Overwijk WW: The immune system in cancer metastasis: Friend or foe?
J Immunother Cancer. 5:792017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Visser KE, Eichten A and Coussens LM:
Paradoxical roles of the immune system during cancer development.
Nat Rev Cancer. 6:24–37. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pernot S, Terme M, Voron T, Colussi O,
Marcheteau E, Tartour E and Taieb J: Colorectal cancer and
immunity: What we know and perspectives. World J Gastroenterol.
20:3738–3750. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Markman JL and Shiao SL: Impact of the
immune system and immunotherapy in colorectal cancer. J
Gastrointest Oncol. 6:208–223. 2015.PubMed/NCBI
|
|
10
|
Fletcher R, Wang YJ, Schoen RE, Finn OJ,
Yu J and Zhang L: Colorectal cancer prevention: Immune modulation
taking the stage. Biochim Biophys Acta Rev Cancer. 1869:138–148.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Laghi L, Bianchi P, Miranda E, Balladore
E, Pacetti V, Grizzi F, Allavena P, Torri V, Repici A, Santoro A,
et al: CD3+ cells at the invasive margin of deeply
invading (pT3-T4) colorectal cancer and risk of post-surgical
metastasis: A longitudinal study. Lancet Oncol. 10:877–884. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang B, Wang Z, Wu L, Zhang M, Li W, Ding
J, Zhu J, Wei H and Zhao K: Circulating and tumor-infiltrating
myeloid-derived suppressor cells in patients with colorectal
carcinoma. PLoS One. 8:e571142013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kryczek I, Wu K, Zhao E, Wei S, Vatan L,
Szeliga W, Huang E, Greenson J, Chang A, Roliński J, et al:
IL-17+ regulatory T cells in the microenvironments of
chronic inflammation and cancer. J Immunol. 186:4388–4395. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Műzes G, Molnár B and Sipos F: Regulatory
T cells in inflammatory bowel diseases and colorectal cancer. World
J Gastroenterol. 18:5688–5694. 2012. View Article : Google Scholar
|
|
16
|
Märkl B, Wieberneit J, Kretsinger H, Mayr
P, Anthuber M, Arnholdt HM and Schenkirsch G: Number of
intratumoral T lymphocytes is associated with lymph node size,
lymph node harvest, and outcome in node-negative colon cancer. Am J
Clin Pathol. 145:826–836. 2016. View Article : Google Scholar
|
|
17
|
Zeng ZS, Huang Y, Cohen AM and Guillem JG:
Prediction of colorectal cancer relapse and survival via tissue RNA
levels of matrix metalloproteinase-9. J Clin Oncol. 14:3133–3140.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Camus M, Tosolini M, Mlecnik B, Pagès F,
Kirilovsky A, Berger A, Costes A, Bindea G, Charoentong P, Bruneval
P, et al: Coordination of intratumoral immune reaction and human
colorectal cancer recurrence. Cancer Res. 69:2685–2693. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Galon J, Pagès F, Marincola FM, Thurin M,
Trinchieri G, Fox BA, Gajewski TF and Ascierto PA: The immune score
as a new possible approach for the classification of cancer. J
Transl Med. 10:12012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang RF and Wang HY: Immune targets and
neoantigens for cancer immunotherapy and precision medicine. Cell
Res. 27:11–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mileo AM, Nisticò P and Miccadei S:
Polyphenols: Immunomodulatory and therapeutic implication in
colorectal cancer. Front Immunol. 10:7292019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nixon AB, Schalper KA, Jacobs I, Potluri
S, Wang IM and Fleener C: Peripheral immune-based biomarkers in
cancer immunotherapy: Can we realize their predictive potential? J
Immunother Cancer. 7:3252019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ciardiello D, Vitiello PP, Cardone C,
Martini G, Troiani T, Martinelli E and Ciardiello F: Immunotherapy
of colorectal cancer: Challenges for therapeutic efficacy. Cancer
Treat Rev. 76:22–32. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chao S, Cheng C and Liew CC: Mining the
dynamic genome: A method for identifying multiple disease
signatures using quantitative RNA expression analysis of a single
blood sample. Microarrays (Basel). 4:671–689. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liew CC, Ma J, Tang HC, Zheng R and
Dempsey AA: The peripheral blood transcriptome dynamically reflects
system wide biology: A potential diagnostic tool. J Lab Clin Med.
147:126–132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mohr S and Liew CC: The peripheral-blood
transcriptome: New insights into disease and risk assessment.
Trends Mol Med. 13:422–432. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liew CC: Method for detection of gene
transcripts in blood and uses thereof. Patent US7598031B2. Filed
October 9, 2002; issued January 22, 2004.
|
|
28
|
Omar H, Lim CR, Chao S, Lee MM, Bong CW,
Ooi EJ, Yu CG, Tan SS, Abu Hassan MR, Menon J, et al: Blood gene
signature for early hepatocellular carcinoma detection in patients
with chronic hepatitis B. J Clin Gastroenterol. 49:150–157. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zaatar AM, Lim CR, Bong CW, Lee MM, Ooi
JJ, Suria D, Raman R, Chao S, Yang H, Neoh SB, et al: Whole blood
transcriptome correlates with treatment response in nasopharyngeal
carcinoma. J Exp Clin Cancer Res. 31:762012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Marshall KW, Mohr S, Khettabi FE, Nossova
N, Chao S, Bao W, Ma J, Li XJ and Liew CC: A blood-based biomarker
panel for stratifying current risk for colorectal cancer. Int J
Cancer. 126:1177–1186. 2010.PubMed/NCBI
|
|
31
|
Chao S, Ying J, Liew G, Marshall W, Liew
CC and Burakoff R: Blood RNA biomarker panel detects both left- and
right-sided colorectal neoplasms: A case-control study. J Exp Clin
Cancer Res. 32:442013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liong ML, Lim CR, Yang H, Chao S, Bong CW,
Leong WS, Das PK, Loh CS, Lau BE, Yu CG, et al: Blood-based
biomarkers of aggressive prostate cancer. PLoS One. 7:e458022012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Osman I, Bajorin DF, Sun TT, Zhong H,
Douglas D, Scattergood J, Zheng R, Han M, Marshall KW and Liew CC:
Novel blood biomarkers of human urinary bladder cancer. Clin Cancer
Res. 12:3374–3380. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mok SC, Kim JH, Skates SJ, Schorge JO,
Cramer DW, Lu KH and Liew CC: Use of blood-based mRNA profiling to
identify biomarkers for ovarian cancer screening. Gynecol Obstet
(Sunnyvale). 7:62017. View Article : Google Scholar
|
|
35
|
Hou H, Lyu Y, Jiang J, Wang M, Zhang R,
Liew CC, Wang B and Cheng C: Peripheral blood transcriptome
identifies high-risk benign and malignant breast lesions. PLoS One.
15:e02337132020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zou C, Lyu Y, Jiang J, Cao Y, Wang M, Sang
C, Zhang R, Li H, Liew CC, Cheng C, et al: Use of peripheral blood
transcriptomic biomarkers to distinguish high-grade cervical
squamous intraepithelial lesions from low-grade lesions. Oncol
Lett. 20:2280–2290. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Q, Luo D, Cai S, Li Q and Li X: P-TNM
staging system for colon cancer: Combination of P-stage and AJCC
TNM staging system for improving prognostic prediction and clinical
management. Cancer Manag Res. 10:2303–2314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Irizarry RA, Bolstad BM, Collin F, Cope
LM, Hobbs B and Speed TP: Summaries of Affymetrix GeneChip probe
level data. Nucleic Acids Res. 31:e152003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shi L, Reid LH, Jones WD, Shippy R,
Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES,
Lee KY, et al MAQC Consortium, : The MicroArray Quality Control
(MAQC) project shows inter- and intraplatform reproducibility of
gene expression measurements. Nat Biotechnol. 24:1151–1161. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sidiropoulos K, Viteri G, Sevilla C, Jupe
S, Webber M, Orlic-Milacic M, Jassal B, May B, Shamovsky V, Duenas
C, et al: Reactome enhanced pathway visualization. Bioinformatics.
33:3461–3467. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang Y, Zhang T, Xiao R, Hao X, Zhang H,
Qu H, Xie B, Wang T and Fang X: Platform-independent approach for
cancer detection from gene expression profiles of peripheral blood
cells. Brief Bioinform. 21:1006–1015. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Algamal ZY and Lee MH: Regularized
logistic regression with adjusted adaptive elastic net for gene
selection in high dimensional cancer classification. Comput Biol
Med. 67:136–145. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ferreira JA: The Benjamini-Hochberg method
in the case of discrete test statistics. Int J Biostat. 3:112007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep. 8:92272018.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mihály Z, Kormos M, Lánczky A, Dank M,
Budczies J, Szász MA and Győrffy B: A meta-analysis of gene
expression-based biomarkers predicting outcome after tamoxifen
treatment in breast cancer. Breast Cancer Res Treat. 140:219–232.
2013. View Article : Google Scholar
|
|
49
|
Zhao F and Yu YQ: The prognostic roles of
mRNAs of the exosomes derived from bone marrow stromal cells in
common malignancies: A bioinformatic study. OncoTargets Ther.
11:7979–7986. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ladabaum U, Dominitz JA, Kahi C and Schoen
RE: Strategies for colorectal cancer screening. Gastroenterology.
158:418–432. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Issa IA and Noureddine M: Colorectal
cancer screening: An updated review of the available options. World
J Gastroenterol. 23:5086–5096. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Puppa G, Sonzogni A, Colombari R and
Pelosi G: TNM staging system of colorectal carcinoma: A critical
appraisal of challenging issues. Arch Pathol Lab Med. 134:837–852.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Roelands J, Kuppen PJK, Vermeulen L,
Maccalli C, Decock J, Wang E, Marincola FM, Bedognetti D and
Hendrickx W: Immunogenomic classification of colorectal cancer and
therapeutic implications. Int J Mol Sci. 18:1–20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ge P, Wang W, Li L, Zhang G, Gao Z, Tang
Z, Dang X and Wu Y: Profiles of immune cell infiltration and
immune-related genes in the tumor microenvironment of colorectal
cancer. Biomed Pharmacother. 118:1092282019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Klee CB and Krinks MH: Purification of
cyclic 3,5-nucleotide phosphodiesterase inhibitory protein by
affinity chromatography on activator protein coupled to Sepharose.
Biochemistry. 17:120–126. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Klee CB, Ren H and Wang X: Regulation of
the calmodulin-stimulated protein phosphatase, calcineurin. J Biol
Chem. 273:13367–13370. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Sharma RK, Desai R, Waisman DM and Wang
JH: Purification and subunit structure of bovine brain modulator
binding protein. J Biol Chem. 254:4276–4282. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Rusnak F and Mertz P: Calcineurin: Form
and function. Physiol Rev. 80:1483–1521. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lakshmikuttyamma A, Selvakumar P, Kanthan
R, Kanthan SC and Sharma RK: Increased expression of calcineurin in
human colorectal adenocarcinomas. J Cell Biochem. 95:731–739. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Sugiura R, Sio SO, Shuntoh H and Kuno T:
Molecular genetic analysis of the calcineurin signaling pathways.
Cell Mol Life Sci. 58:278–288. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Song E, Chen J, Antus B, Wang M, Xie Y,
Yao H and Exton MS: Interleukin-2 enhances susceptibility of colon
cancer cells to FasR mediated apoptosis by up-regulating Fas
receptor level and down-regulating FAP-1 expression. Int J
Immunopathol Pharmacol. 13:113–122. 2000.PubMed/NCBI
|
|
62
|
Gang W, Yu-Zhu W, Yang Y, Feng S, Xing-Li
F and Heng Z: The critical role of calcineurin/NFAT (C/N) pathways
and effective antitumor prospect for colorectal cancers. J Cell
Biochem. 120:19254–19273. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Peuker K, Muff S, Wang J, Künzel S, Bosse
E, Zeissig Y, Luzzi G, Basi M, Strigli A, Ulbricht A, et al:
Epithelial calcineurin controls microbiota-dependent intestinal
tumor development. Nat Med. 22:506–515. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Thomas H: Colorectal cancer: Calcineurin
drives CRC tumorigenesis. Nat Rev Gastroenterol Hepatol.
13:2492016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
O'Brien RJ and Wong PC: Amyloid precursor
protein processing and Alzheimer's disease. Annu Rev Neurosci.
34:185–204. 2011. View Article : Google Scholar
|
|
66
|
Mattson MP: Cellular actions of
beta-amyloid precursor protein and its soluble and fibrillogenic
derivatives. Physiol Rev. 77:1081–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Meng JY, Kataoka H, Itoh H and Koono M:
Amyloid beta protein precursor is involved in the growth of human
colon carcinoma cell in vitro and in vivo. Int J Cancer. 92:31–39.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Venkataramani V, Rossner C, Iffland L,
Schweyer S, Tamboli IY, Walter J, Wirths O and Bayer TA: Histone
deacetylase inhibitor valproic acid inhibits cancer cell
proliferation via down-regulation of the alzheimer amyloid
precursor protein. J Biol Chem. 285:10678–10689. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Roe CM, Fitzpatrick AL, Xiong C, Sieh W,
Kuller L, Miller JP, Williams MM, Kopan R, Behrens MI and Morris
JC: Cancer linked to Alzheimer disease but not vascular dementia.
Neurology. 74:106–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kirschke H, Langner J, Riemann S,
Wiederanders B, Ansorge S and Bohley P: Lysosomal cysteine
proteinases. Ciba Found Symp. 75:15–35. 1979.PubMed/NCBI
|
|
71
|
Lafuse WP, Brown D, Castle L and Zwilling
BS: IFN-gamma increases cathepsin H mRNA levels in mouse
macrophages. J Leukoc Biol. 57:663–669. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Nitatori T, Sato N, Kominami E and
Uchiyama Y: Participation of cathepsins B, H, and L in perikaryal
condensation of CA1 pyramidal neurons undergoing apoptosis after
brief ischemia. Adv Exp Med Biol. 389:177–185. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Mithöfer K, Fernández-del Castillo C,
Rattner D and Warshaw AL: Subcellular kinetics of early trypsinogen
activation in acute rodent pancreatitis. Am J Physiol. 274:G71–G79.
1998.
|
|
74
|
Williams ST and Beart RW Jr: Staging of
colorectal cancer. Semin Surg Oncol. 8:89–93. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Durdey P, Cooper JC, Switala S, King RF
and Williams NS: The role of peptidases in cancer of the rectum and
sigmoid colon. Br J Surg. 72:378–381. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
del Re EC, Shuja S, Cai J and Murnane MJ:
Alterations in cathepsin H activity and protein patterns in human
colorectal carcinomas. Br J Cancer. 82:1317–1326. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Schweiger A, Christensen IJ, Nielsen HJ,
Sørensen S, Brünner N and Kos J: Serum cathepsin H as a potential
prognostic marker in patients with colorectal cancer. Int J Biol
Markers. 19:289–294. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Hershberg RM, Framson PE, Cho DH, Lee LY,
Kovats S, Beitz J, Blum JS and Nepom GT: Intestinal epithelial
cells use two distinct pathways for HLA class II antigen
processing. J Clin Invest. 100:204–215. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Song H and Ji X: The mechanism of RNA
duplex recognition and unwinding by DEAD-box helicase DDX3X. Nat
Commun. 10:30852019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Sharma D and Jankowsky E: The Ded1/DDX3
subfamily of DEAD-box RNA helicases. Crit Rev Biochem Mol Biol.
49:343–360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Guenther UP, Weinberg DE, Zubradt MM,
Tedeschi FA, Stawicki BN, Zagore LL, Brar GA, Licatalosi DD, Bartel
DP, Weissman JS, et al: The helicase Ded1p controls use of
near-cognate translation initiation codons in 5 UTRs. Nature.
559:130–134. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Zhao L, Mao Y, Zhou J, Zhao Y, Cao Y and
Chen X: Multifunctional DDX3: Dual roles in various cancer
development and its related signaling pathways. Am J Cancer Res.
6:387–402. 2016.PubMed/NCBI
|
|
83
|
Su CY, Lin TC, Lin YF, Chen MH, Lee CH,
Wang HY, Lee YC, Liu YP, Chen CL and Hsiao M: DDX3 as a strongest
prognosis marker and its downregulation promotes metastasis in
colorectal cancer. Oncotarget. 6:18602–18612. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Heerma van Voss MR, Vesuna F, Trumpi K,
Brilliant J, Berlinicke C, de Leng W, Kranenburg O, Offerhaus GJ,
Bürger H, van der Wall E, et al: Identification of the DEAD box RNA
helicase DDX3 as a therapeutic target in colorectal cancer.
Oncotarget. 6:28312–28326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Cao J, Wang Y, Dong R, Lin G, Zhang N,
Wang J, Lin N, Gu Y, Ding L, Ying M, et al: Hypoxia-induced WSB1
promotes the metastatic potential of osteosarcoma cells. Cancer
Res. 75:4839–4851. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Schmidt M, Haas W, Crosas B, Santamaria
PG, Gygi SP, Walz T and Finley D: The HEAT repeat protein Blm10
regulates the yeast proteasome by capping the core particle. Nat
Struct Mol Biol. 12:294–303. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Qian MX, Pang Y, Liu CH, Haratake K, Du
BY, Ji DY, Wang GF, Zhu QQ, Song W, Yu Y, et al:
Acetylation-mediated proteasomal degradation of core histones
during DNA repair and spermatogenesis. Cell. 153:1012–1024. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Blickwedehl J, Olejniczak S, Cummings R,
Sarvaiya N, Mantilla A, Chanan-Khan A, Pandita TK, Schmidt M,
Thompson CB and Bangia N: The proteasome activator PA200 regulates
tumor cell responsiveness to glutamine and resistance to ionizing
radiation. Mol Cancer Res. 10:937–944. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Boland CR and Goel A: Microsatellite
instability in colorectal cancer. Gastroenterology.
138:2073–2087.e3. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Chang L, Chang M, Chang HM and Chang F:
Microsatellite instability: A predictive biomarker for cancer
immunotherapy. Appl Immunohistochem Mol Morphol. 26:e15–e21. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Lucas C, Barnich N and Nguyen HTT:
Microbiota, inflammation and colorectal cancer. Int J Mol Sci.
18:13102017. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Halfvarson J, Brislawn CJ, Lamendella R,
Vázquez-Baeza Y, Walters WA, Bramer LM, D'Amato M, Bonfiglio F,
McDonald D, Gonzalez A, et al: Dynamics of the human gut microbiome
in inflammatory bowel disease. Nat Microbiol. 2:170042017.
View Article : Google Scholar : PubMed/NCBI
|
